Helen Of Troy Limited's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Helen Of Troy Limited (HELE) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Helen Of Troy Limited vs Its Competitors
- TTM: Trailing 12-month revenue of 1,817M vs 669,627M combined for tracked competitors (0.3% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-11.5% annualized vs trailing 12 months), vs holding steady (+1.2%) for its tracked peer group.
- Growth: Helen Of Troy Limited generated 8.4% revenue growth year over year in Q1 2026, vs 6.1% for its tracked competitors combined.
- Profitability: Its 8.9% net margin compares with 4.8% for the peer group.
- Scale: Helen Of Troy Limited ranks #9 of 24 companies by market capitalization in the Conglomerates industry, holding 0.2% of industry market cap.
- Peer revenue share: Helen Of Troy Limited accounted for 0.2% of combined revenue among its tracked peer group, up from 0.2% a year earlier.
- Peer differentiation: Revenue per employee of $0.98M compares with $1.17M for the peer group (0.8x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
HELE Sales vs. its Competitors, Q1 2026
Helen Of Troy Limited reported revenue growth of 8.38 % year on year in Q1 2026, above its competitors' combined revenue growth of 6.14 %.
With a net margin of 8.89 %, Helen Of Troy Limited achieved higher profitability than its competitors (4.80 %).
Helen Of Troy Limited generated 0.24 % of the combined sales of its peer group, up from 0.23 % a year earlier.
Helen Of Troy Limited vs. its Competitors, Q1 2026
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Helen Of Troy Limited and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Helen Of Troy Limited | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (11) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (9) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (6) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Helen Of Troy Limited's competitor groups requires a Commercial License.
For context: the Conglomerates industry grew revenue 13.0% year over year, combined, vs 8.4% for Helen Of Troy Limited. Helen Of Troy Limited's share of combined industry revenue moved from 0.40% to 0.38%, a loss of 0.02 percentage points.
Helen Of Troy Limited's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Helen Of Troy Limited | No | No | No | Yes |
| Competitors combined (20) | ||||
| High-Confidence Competitors (14) | ||||
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 37.50 % (3 of 8) | 37.50 % (3 of 8) | 37.50 % (3 of 8) | 25.00 % (2 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
HELE Stock Performance relative to its Competitors
HELE Stock Performance relative to High-Confidence Competitors
HELE Stock Performance relative to Similar-Size Competitors
HELE Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Corning Inc | 282.9% | Outperformed |
| 2 | European Wax Center Inc | 282.9% | Outperformed |
| 3 | Thermo Fisher Scientific Inc | 282.9% | Outperformed |
| 4 | Cardinal Health Inc | 282.9% | Outperformed |
| 5 | Sensient Technologies Corp | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Helen Of Troy Limited's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Helen Of Troy Limited's Comment on Competition and Industry Peers
Publicly Traded Peers of Helen Of Troy Limited
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Helen Of Troy Limited | 651.21 | 1,816.80 |
| Procter and Gamble Co | 352,061.93 | 87,032.00 |
| Thermo Fisher Scientific Inc | 250,443.55 | 46,336.00 |
| Abbott Laboratories | 172,663.22 | 45,134.00 |
| Corning Inc | 134,531.25 | 16,964.00 |
| Mckesson Corporation | 101,774.15 | 410,983.00 |
| SUBTOTAL | 1,324,339.24 | 980,800.87 |
Sign in to see all competitors of Helen Of Troy Limited.
Sources: Helen Of Troy Limited's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Helen Of Troy Limited versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Helen Of Troy Limited's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Deuter | Named by the company | 85% |
| Guardian Technologies LLC | Named by the company | 85% |
| Newell Brands Inc. | Named by the company | 85% |
| SharkNinja, Inc. | Named by the company | 85% |
| The Procter & Gamble Company | Named by the company | 85% |
| Yeti Holdings, Inc. | Named by the company | 85% |
| CamelBak | Named by the company | 85% |
| Coty Inc. | Named by the company | 85% |
| Exergen Corporation | Named by the company | 85% |
| L’Oréal S.A. | Named by the company | 85% |
| PMI Worldwide | Named by the company | 85% |
| The Clorox Company | Named by the company | 85% |
| Unilever | Named by the company | 85% |
| Bradshaw International | Named by the company | 85% |
| Corning Incorporated | Named by the company | 85% |
| DevaCurl | Named by the company | 85% |
| Lasko Products, LLC. | Named by the company | 85% |
| Omron Healthcare, Inc. | Named by the company | 85% |
| Simple Human LLC | Named by the company | 85% |
| Thule Group | Named by the company | 85% |
| Zero Technologies, LLC | Named by the company | 85% |
| Colgate-Palmolive Company | Named by the company | 85% |
| Crane Enginee | Named by the company | 85% |
| Gregory Mountain Products | Named by the company | 85% |
| Meyer Corporation | Named by the company | 85% |
| Progressive International | Named by the company | 85% |
| The North Face | Named by the company | 85% |
| Vornado Air Circulation Systems | Named by the company | 85% |
| Breville Group | Named by the company | 85% |
| Cotopaxi | Named by the company | 85% |
| Dyson Ltd | Named by the company | 85% |
| Lifetime Brands, Inc. | Named by the company | 85% |
| Patagonia | Named by the company | 85% |
| Spectrum Brands Holdings Inc. | Named by the company | 85% |
| Bradshaw Home, Inc. | Named by the company | 85% |
| Trove Brands, LLC | Named by the company | 85% |
| Spectrum Brands Holdings Inc. | Named by the company | 85% |
| Conair | Named by the company | 85% |
| Kimberly clark Corporation | Named by the company | 85% |
| Avon Products Inc | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Helen Of Troy Limited's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Helen Of Troy Limited's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Helen Of Troy Limited | Beauty & Wellness 51.53 % |
| Procter and Gamble Co | Fabric & Home Care 34.83 % |
| Thermo Fisher Scientific Inc | Clinical Research 19.98 % |
| Abbott Laboratories | Diabetes Care 17.78 % |
| Corning Inc | Optical Communications 40.55 % |
| Mckesson Corporation | North American Pharmaceutical 83.45 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Helen Of Troy Limited.
Helen Of Troy Limited's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Helen Of Troy Limited | 651 | 979,934 | -222,493 |
| Procter and Gamble Co | 352,062 | 836,846 | 155,231 |
| Thermo Fisher Scientific Inc | 250,444 | 370,688 | 55,912 |
| Abbott Laboratories | 172,663 | 392,470 | 54,574 |
| Corning Inc | 134,531 | 252,440 | 30,863 |
| Mckesson Corporation | 101,774 | 8,058,490 | 103,922 |
| PEERS TOTAL | 1,323,688 | 1,168,184 | 52,911 |
Sign in to see all peers for Helen Of Troy Limited.
Helen Of Troy Limited's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Helen Of Troy Limited | United States 76.43 % |
| Procter and Gamble Co | Non-US 52.05 % |
| Thermo Fisher Scientific Inc | North America 51.27 % |
| Abbott Laboratories | Non-US 61.62 % |
| 3m Company | Americas 54.09 % |
| Cardinal Health Inc | United States 99.35 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Helen Of Troy Limited.
Helen Of Troy Limited's Position in Industry Market Structure
Market-capitalization share and concentration across all 23 companies in Helen Of Troy Limited's industry classification, broader than the peer set above. Market cap in millions of $.Helen Of Troy Limited ranks #9 of 23 companies by market capitalization in its industry, holding 0.16 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 4,426, indicating a highly concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Rtx Corporation | 253,412 | 63.33 % |
| 2 | Honeywell International Inc | 67,205 | 16.80 % |
| 3 | Heico Corporation | 42,830 | 10.70 % |
| 4 | Interdigital Inc | 11,171 | 2.79 % |
| 5 | Solstice Advanced Materials Inc | 1,234 | 5.2% |
| 6 | Standardaero Inc | 1,234 | 5.2% |
| 7 | Dolby Laboratories Inc | 1,234 | 5.2% |
| 8 | Digital Turbine Inc | 1,234 | 5.2% |
| 9 | Helen Of Troy Limited | 651 | 0.16 % |
| 10 | Hamilton Beach Brands Holding Company | 1,234 | 5.2% |
Market cap and industry share for the rest of Helen Of Troy Limited's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-30.
Helen Of Troy Limited's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 4 | Interdigital Inc | 11,171 | -5.69 % |
| 5 | Solstice Advanced Materials Inc | 8,977 | - |
| 6 | Standardaero Inc | 7,095 | -18.27 % |
| 7 | Dolby Laboratories Inc | 5,555 | -19.02 % |
| 8 | Digital Turbine Inc | 1,234 | 12.3% |
| 9 | Helen Of Troy Limited | 651 | 9.17 % |
| 10 | Hamilton Beach Brands Holding Company | 1,234 | 12.3% |
| 11 | Tat Technologies Ltd | 1,234 | 12.3% |
| 12 | Acacia Research Corporation | 1,234 | 12.3% |
| 13 | Sifco Industries Inc | 1,234 | 12.3% |
| 14 | Dmc Global Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Helen Of Troy Limited's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-30. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Helen Of Troy Limited's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Conglomerates industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (24 companies). See the full Conglomerates industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 45.44 % | 45.94 % (avg) | -0.5 pp |
| Operating Margin | -17.32 % | industry median | -24.6 pp |
| EBITDA Margin | -17.19 % | 7.94 % (avg) | -25.1 pp |
| Capital Intensity (Capex / Revenue) | 1.74 % | 3.77 % (avg) | -2.0 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Helen Of Troy Limited's Valuation vs Competitive Position
Valuation multiples vs the Conglomerates industry average (24 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Conglomerates industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 22.1x | - |
| EV / EBITDA | - | 13.6x | - |
| P/B | 0.6x | 2.6x | -2.0x |
| Return on Equity | -38.81 % | industry aggregate | -56.93 % |
| Return on Invested Capital | -10.34 % | 3.27 % (avg) | -13.61 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Helen Of Troy Limited's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 1.39 % | -5.73 % | 11.64 % | 23.15 % | -0.29 % | -3.49 % | -4.39 % | -5.71 % |
| Operating Margin | 2.67 % | 21.86 % | 13.64 % | 12.51 % | 9.17 % | 12.39 % | 10.83 % | -40.46 % |
| Return on Invested Capital | 1.68 % | 13.46 % | 9.04 % | 8.75 % | 5.03 % | 6.44 % | 5.15 % | -19.40 % |
| P/E | 127.0x | 18.1x | 22.4x | 23.9x | 17.6x | 16.5x | 13.3x | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Helen Of Troy Limited's Strategic Group Map
Every company in Helen Of Troy Limited's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Helen Of Troy Limited is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Helen Of Troy Limited's BCG Growth-Share Matrix
Relative market share (vs Helen Of Troy Limited's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Helen Of Troy Limited falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 0.8% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution. A caveat worth reading alongside this chart: Rtx Corporation alone holds 63% of this industry's market cap. In an industry this dominated by one leader, the framework will place nearly every OTHER company in "Dog" or "Question Mark" purely because relative share is measured against that leader, regardless of how strong those other companies actually are on their own fundamentals. Check the Profitability, Valuation and Financial Strength sections above before treating this quadrant label as a verdict.
Helen Of Troy Limited's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Low | Industry HHI of 4,426 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 1.74 % vs industry average 3.77 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Helen Of Troy Limited's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Helen Of Troy Limited's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Helen Of Troy Limited's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Helen Of Troy Limited falls in the Medium attractiveness / Low strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Helen Of Troy Limited's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Operating margin 24.6 points below the industry median.
- Return on equity 56.9 points below the industry aggregate.
- Latest-quarter revenue run-rate is decelerating (-11.5% annualized vs trailing 12 months).
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.00x).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
- Industry dominated by Rtx Corporation, holding 63.33 % of industry market cap.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Helen Of Troy Limited's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Helen Of Troy Limited | 0.04 | 1.79 | 0.78 |
| Procter and Gamble Co | 0.25 | 0.71 | 0.71 |
| Thermo Fisher Scientific Inc | 0.32 | 1.62 | 0.78 |
| Abbott Laboratories | 0.47 | 1.60 | 0.35 |
| Corning Inc | 0.25 | 1.64 | 0.68 |
| Mckesson Corporation | 0.07 | 0.88 | - |
Sign in to see all peers for Helen Of Troy Limited.
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Helen Of Troy Limited's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Helen Of Troy Limited | Q2 2026 | +8.4 % | - |
| Procter and Gamble Co | Q2 2026 | +1.5 % | -15.0 % |
| Thermo Fisher Scientific Inc | Q2 2026 | +10.5 % | +7.6 % |
| Abbott Laboratories | Q1 2026 | +7.8 % | -18.7 % |
| Corning Inc | Q2 2026 | +16.6 % | +21.8 % |
| Mckesson Corporation | Q2 2026 | +7.7 % | +24.2 % |
| PEERS TOTAL | +7.3 % | -2.7 % |
Sign in to see all peers for Helen Of Troy Limited.
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Helen Of Troy Limited's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Helen Of Troy Limited | Q2 2026 | +10.8 % | -56.5 % |
| Procter and Gamble Co | Q2 2026 | +2.7 % | +2.7 % |
| Thermo Fisher Scientific Inc | Q2 2026 | +142.5 % | +53.1 % |
| Abbott Laboratories | Q1 2026 | +9.4 % | -17.6 % |
| Corning Inc | Q2 2026 | +16.5 % | +37.0 % |
| Mckesson Corporation | Q2 2026 | +7.6 % | -19.6 % |
Sign in to see all peers for Helen Of Troy Limited.
Helen Of Troy Limited's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Helen Of Troy Limited | - | - | - |
| Procter and Gamble Co | 12.72% | 17.81% | 30.05% |
| Thermo Fisher Scientific Inc | 6.36% | 7.71% | 13.37% |
| Abbott Laboratories | 6.87% | 8.15% | 12.09% |
| Corning Inc | 6.63% | 8.04% | 16.66% |
| Mckesson Corporation | 6.43% | 35.05% | - |
Sign in to see all peers for Helen Of Troy Limited.
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Helen Of Troy Limited's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Helen Of Troy Limited | - | 0.36 |
| Procter and Gamble Co | 22.05 | 4.05 |
| Thermo Fisher Scientific Inc | 36.33 | 5.40 |
| Abbott Laboratories | 27.53 | 3.83 |
| Corning Inc | 70.21 | 7.93 |
| Mckesson Corporation | 22.95 | 0.25 |
| PEERS AVERAGE | 30.15 | 1.35 |
Sign in to see all peers for Helen Of Troy Limited.
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.